Panel session I - A clinical and systems perspective on tobacco control: the AHCPR guideline - Questions and answers

被引:0
|
作者
Marcy, T [1 ]
Curry, S
Fiore, M
Simmons, R
Roski, J
Murford, B
Mcafee, T
An, L
Barnett, P
Williams, C
机构
[1] Univ Vermont, Burlington, VT 05405 USA
[2] Christiana Care, Wilmington, DE USA
[3] Hlth Plan Redwoods, Santa Rosa, CA USA
[4] Grp Hlth Cooperat, Washington, DC USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Presbyterian Hlth Plan, Albuquerque, NM USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:S24 / S25
页数:2
相关论文
共 25 条
  • [1] Questions and answers - Session I: Clinical trials and beyond
    Bowyer, J
    Paule, M
    Doyle, A
    Todorovic, V
    Reiter, R
    Lin, A
    Mervis, R
    Isaacson, B
    Lubitz, V
    Skaper, S
    Slikker, W
    Mandel, S
    NEUROPROTECTIVE AGENTS, 2003, 993 : 48 - 53
  • [2] Panel session III - Measuring results: understanding and implementing tobacco measures - Questions and answers
    Davis, R
    Mcafee, T
    Jessen, J
    Young, S
    Rigotti, N
    Merberg, B
    Harmon, B
    TOBACCO CONTROL, 1998, 7 : S47 - S49
  • [3] Questions and answers of session I - Synaptic transmission
    Tsien
    Treistman
    DRUNKEN SYNAPSE: STUDIES OF ALCOHOL-RELATED DISORDERS, 1999, : 63 - 76
  • [4] Panel session II - Linking to public health resources - Questions and answers
    Dorfman, SF
    Eriksen, M
    Sandell, S
    Adams, J
    Oakes, JD
    Morgan, G
    Lead, B
    Seghers, T
    Marcy, T
    Fay, B
    Schilling, A
    Windsor, R
    Gaines, MB
    Mcafee, T
    Shwartz, S
    TOBACCO CONTROL, 1998, 7 : S32 - S35
  • [5] Questions and answers - Session II: Clinical application of neuroprotective approaches
    Paule, M
    Ritchie, G
    Bowyer, J
    Reiter, R
    Lubitz, V
    NEUROPROTECTIVE AGENTS, 2003, 993 : 79 - 81
  • [6] LUCAS ANSWERS QUESTIONS ABOUT THEIR CAR CONTROL-SYSTEMS
    RAYNER, CS
    WILLIAMS, M
    SAE JOURNAL OF AUTOMOTIVE ENGINEERS, 1972, 80 (03): : 36 - &
  • [7] Questions and answers following session III. Clinical detection and measurement of optic nerve damage
    Burk, R
    Weinreb, R
    Sample, P
    Johnson, C
    Cioffi, G
    SURVEY OF OPHTHALMOLOGY, 2001, 45 : S332 - S334
  • [8] Questions and answers following session I. Location of injury and mechanism of retinal ganglion cell death
    Sample, P
    Schwartz, M
    Levin, L
    Johnson, C
    Vidal-Sanz, M
    Tatton, N
    Cioffi, G
    Dreyer, E
    Weinreb, R
    SURVEY OF OPHTHALMOLOGY, 2001, 45 : S273 - S276
  • [9] Systems perspective for equitable tobacco control in the future
    Kuipers, Mirte A. G.
    TOBACCO CONTROL, 2022, 31 (02) : 386 - 386
  • [10] ChatGPT Responses to Frequently Asked Questions on Meniere's Disease: A Comparison to Clinical Practice Guideline Answers
    Ho, Rebecca A.
    Shaari, Ariana L.
    Cowan, Paul T.
    Yan, Kenneth
    OTO OPEN, 2024, 8 (03)